The Latest Breaking News from Gallant

Big Bucks For Better Barks: Gallant Lands $18M To Bring Game-Changing Stem Cell Therapies To Pets

San Diego biotech startup Gallant just raised $18 million in a Series B financing round, furthering its quest to deliver the first ready-to-use stem cell therapy through conditional U.S. Food and Drug Administration approval. But the company isn't directing those funds toward the treatment of sick humans. Rather, it's wants…

Benzinga · Jul 16, 2025

Glasgow University project promises ‘significant boost’ to city’s Cop26 legacy

The Gallant project is going ahead after winning funding from the Natural Environment Research Council.

The Independent UK · Feb 15, 2022